Bacterial Vaginosis, Trichomonal Vaginitis, Vaginal Candidiasis
Conditions
Keywords
Vaginal candidiasis, Bacterial vaginosis (also known as non-specific, or Gardnerellosis, or anaerobic vaginosis), Trichomonal vaginitis, Vaginitis due to mixed infection
Brief summary
Vaginitis is the most common gynecologic diagnosis in the primary care setting. In approximately 90 percent of affected women, this condition occurs secondary to bacterial vaginosis, vulvovaginal candidiasis, trichomoniasis or mixed infection. Neo-Penotran Forte is registered for treatment of these most common vaginal infections. Efficacy and safety of this product is already established, and this observational study was designed to learn more about practical use of Neo-Penotran® Forte in real life setting.
Interventions
DRUGMetronidazole/Miconazole (Neo-Penotran Forte, BAY86-5276)
Patients older than 18 years with previously taken decision of their gynecologist to prescribe Neo-Penotran Forte according to registered indications, and microbiological tests were performed.
Sponsors
Bayer
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 90 Years
Healthy volunteers
No
Inclusion criteria
* Patients older than 18 years with previously taken decision of their gynecologist to prescribe Neo-Penotran Forte according to registered indications, and microbiological tests were performed.
Exclusion criteria
* Presence of contraindications according to package insert.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percent rate of different vaginal infections | Approximately within 6 months after the last patient last visit. |
Secondary
| Measure | Time frame |
|---|---|
| Clinical characteristics of vaginitis after treatment. | Depending on treatment time chosen by the physician, after 7 or 14 days. |
| Change of microbiological characteristics after treatment | Depending on treatment time chosen by the physician, after 7 or 14 days. |
| Patient rating of tolerability and treatment results | Depending on treatment time chosen by the physician, after 7 or 14 days. |
| Physician's rating of tolerability and treatment results | Depending on treatment time chosen by the physician, after 7 or 14 days. |
Countries
Kazakhstan
Outcome results
None listed